87 related articles for article (PubMed ID: 10602041)
1. Deficiency of IL-2 or IL-6 reduces lymphocyte proliferation, but only IL-6 deficiency decreases the contact hypersensitivity response.
Hope JC; Campbell F; Hopkins SJ
Eur J Immunol; 2000 Jan; 30(1):197-203. PubMed ID: 10602041
[TBL] [Abstract][Full Text] [Related]
2. Contact sensitization to oxazolone: involvement of both interferon-gamma and interleukin-4 in oxazolone-specific Ig and T-cell responses.
Thomson JA; Troutt AB; Kelso A
Immunology; 1993 Feb; 78(2):185-92. PubMed ID: 8473011
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between interleukin-6 production by contact allergen-activated draining lymph node cells and lymphoproliferative activity.
Lappin MB; Dearman RJ; Norval M; Kimber I
Am J Contact Dermat; 1998 Mar; 9(1):34-9. PubMed ID: 9471985
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide denervation alters both the elicitation and induction phases of contact hypersensitivity in mice.
Veronesi B; Williams WC; Smialowicz RJ; Sailstad DM; Doerfler D; Selgrade MJ
Toxicol Appl Pharmacol; 1998 Dec; 153(2):243-9. PubMed ID: 9878594
[TBL] [Abstract][Full Text] [Related]
5. The kinetics of cytokine production by draining lymph node cells following primary exposure of mice to chemical allergens.
Hope JC; Dearman RJ; Kimber I; Hopkins SJ
Immunology; 1994 Oct; 83(2):250-5. PubMed ID: 7835943
[TBL] [Abstract][Full Text] [Related]
6. Correlation between keratinocyte expression of Ia and the intensity and duration of contact hypersensitivity responses in mice.
Roberts LK; Spangrude GJ; Daynes RA; Krueger GG
J Immunol; 1985 Nov; 135(5):2929-36. PubMed ID: 3862711
[TBL] [Abstract][Full Text] [Related]
7. B cells are not required for T cell priming in low zone tolerance to contact allergens and contact hypersensitivity.
Seidel-Guyenot W; Alt R; Perschon S; Knop J; Steinbrink K
Eur J Immunol; 2004 Nov; 34(11):3082-90. PubMed ID: 15376190
[TBL] [Abstract][Full Text] [Related]
8. Inducible interleukin-4-secreting cells provoked in mice during chemical sensitization.
Dearman RJ; Ramdin LS; Basketter DA; Kimber I
Immunology; 1994 Apr; 81(4):551-7. PubMed ID: 8039807
[TBL] [Abstract][Full Text] [Related]
9. Distinct in vivo and in vitro cytokine profiles of draining lymph node cells in acute and chronic phases of contact hypersensitivity: importance of a type 2 cytokine-rich cutaneous milieu for the development of an early-type response in the chronic phase.
Kitagaki H; Kimishima M; Teraki Y; Hayakawa J; Hayakawa K; Fujisawa S; Shiohara T
J Immunol; 1999 Aug; 163(3):1265-73. PubMed ID: 10415023
[TBL] [Abstract][Full Text] [Related]
10. Production of interleukin-1 by draining lymph node cells during the induction phase of contact sensitization in mice.
Hopkins SJ; Humphreys M; Kinnaird A; Jones DA; Kimber I
Immunology; 1990 Dec; 71(4):493-6. PubMed ID: 2279734
[TBL] [Abstract][Full Text] [Related]
11. Identification of dendritic cells as a major source of interleukin-6 in draining lymph nodes following skin sensitization of mice.
Hope JC; Cumberbatch M; Fielding I; Dearman RJ; Kimber I; Hopkins SJ
Immunology; 1995 Nov; 86(3):441-7. PubMed ID: 8550083
[TBL] [Abstract][Full Text] [Related]
12. Primary immune response in skin and skin-associated lymphoid tissue of interleukin-4 transgenic mice.
Blümel J; Schimpl A; Ulrich P; Ahr HJ; Vohr H
Eur Cytokine Netw; 1999 Dec; 10(4):515-24. PubMed ID: 10586118
[TBL] [Abstract][Full Text] [Related]
13. Arsenic-induced alterations in the contact hypersensitivity response in Balb/c mice.
Patterson R; Vega L; Trouba K; Bortner C; Germolec D
Toxicol Appl Pharmacol; 2004 Aug; 198(3):434-43. PubMed ID: 15276424
[TBL] [Abstract][Full Text] [Related]
14. Role of Fas/Fas ligand-mediated apoptosis in murine contact hypersensitivity.
Xu B; Bulfone-Paus S; Aoyama K; Yu S; Huang P; Morimoto K; Matsushita T; Takeuchi T
Int Immunopharmacol; 2003 Jul; 3(7):927-38. PubMed ID: 12810350
[TBL] [Abstract][Full Text] [Related]
15. IL-1beta, but not IL-1alpha, is required for antigen-specific T cell activation and the induction of local inflammation in the delayed-type hypersensitivity responses.
Nambu A; Nakae S; Iwakura Y
Int Immunol; 2006 May; 18(5):701-12. PubMed ID: 16569679
[TBL] [Abstract][Full Text] [Related]
16. Assessment of preferential T-helper 1 or T-helper 2 induction by low molecular weight compounds using the local lymph node assay in conjunction with RT-PCR and ELISA for interferon-gamma and interleukin-4.
Vandebriel RJ; De Jong WH; Spiekstra SW; Van Dijk M; Fluitman A; Garssen J; Van Loveren H
Toxicol Appl Pharmacol; 2000 Jan; 162(2):77-85. PubMed ID: 10637130
[TBL] [Abstract][Full Text] [Related]
17. Contact and respiratory sensitizers can be identified by cytokine profiles following inhalation exposure.
De Jong WH; Arts JH; De Klerk A; Schijf MA; Ezendam J; Kuper CF; Van Loveren H
Toxicology; 2009 Jul; 261(3):103-11. PubMed ID: 19422874
[TBL] [Abstract][Full Text] [Related]
18. Impaired contact hypersensitivity in macrophage migration inhibitory factor-deficient mice.
Shimizu T; Abe R; Nishihira J; Shibaki A; Watanabe H; Nakayama T; Taniguchi M; Ishibashi T; Shimizu H
Eur J Immunol; 2003 Jun; 33(6):1478-87. PubMed ID: 12778465
[TBL] [Abstract][Full Text] [Related]
19. Requirements for antigenic competition in contact sensitivity.
Kimber I; Cumberbatch M; Bentley AN; Baker D
J Clin Lab Immunol; 1990 Jun; 32(2):67-72. PubMed ID: 1967041
[TBL] [Abstract][Full Text] [Related]
20. Cytokine production induced by low-molecular-weight chemicals as a function of the stimulation index in a modified local lymph node assay: an approach to discriminate contact sensitizers from respiratory sensitizers.
Van Och FM; Van Loveren H; De Jong WH; Vandebriel RJ
Toxicol Appl Pharmacol; 2002 Oct; 184(1):46-56. PubMed ID: 12392968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
